Severe anemia caused by the angiotensin receptor blocker irbesartan after renal transplantation [1]

Pediatric Nephrology

Volumn 22, Issue 5, 2007, Pages 756-757

  Simonetti, Giacomo D ^a   Bianchetti, Mario G ^b   Konrad, Martin ^a   von Vigier, Rodo O ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Ospedale Mendrisio and Bellinzona   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AZATHIOPRINE; CYCLOSPORIN A; HEMOGLOBIN; IRBESARTAN; IRON; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANTIHYPERTENSIVE THERAPY; CADAVER DONOR; CASE REPORT; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHOOL CHILD;

ANEMIA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; CHILD; ERYTHROPOIETIN; HEMOGLOBINS; HUMANS; IRON; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; TETRAZOLES; TREATMENT OUTCOME;

EID: 34247849207     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0400-3     Document Type: Letter

References (7)

1. Afzali B, Al-Khoury S, Shah N, Mikhail A, Covic A, Goldsmith D (2006) Anemia after renal transplantation. Am J Kidney Dis 48:519-536
2. Karalliedde J, Viberti G (2006) Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. J Hum Hypertens 20:239-253
3. Gartenmann AC, Fossali E, von Vigier RO, Simonetti GD, Schmidtko J, Edefonti A, Bianchetti MG (2003) Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int 64:1450-1454
4. Yim HE, Kim MK, Bae IS, Kim JH, Choi BM, Yoo KH, Hong YS, Lee JW (2006) AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney. Pediatr Nephrol 21:1377-1388
5. Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH (2005) Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 68:1190-1198
6. Ersoy A, Kahvecioglu S, Ersoy C, Cift A, Dilek K (2005) Anemia due to losartan in hypertensive renal transplant recipients without posttransplant erythrocytosis. Transplant Proc 37:2148-2150
7. Sackey AH (1998) Anaemia after enalapril in a child with nephrotic syndrome. Lancet 352:285-286